Structure - Activity studies leading to ( - )1-(Benzofuran-2-yl)-2-propylaminopentane, (( - )BPAP), a highly potent, selective enhancer of the impulse propagation mediated release of catecholamines and serotonin in the brain

Bioorganic and Medicinal Chemistry

Volumn 9, Issue 5, 2001, Pages 1197-1212

  Yoneda, Fumio ^a   Moto, Toshiaki ^a   Sakae, Masatoshi ^a   Ohde, Hironori ^a   Knoll, Berta ^b   Miklya, Ildikó ^b   Knoll, Joseph ^b  

^a Fujimoto Pharmaceutical Corporation   (Japan)

^b SEMMELWEIS UNIVERSITY OF MEDICINE   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

1 (BENZOFURAN 2 YL) 2 PROPYLAMINOPENTANE; 1 PHENYL 2 PROPYLAMINOPENTANE; ALKANE DERIVATIVE; AMINOALKANE DERIVATIVE; AMPHETAMINE DERIVATIVE; AMYLOID BETA PROTEIN; BENZOFURAN DERIVATIVE; CATECHOLAMINE; DOPAMINE; MONOAMINE OXIDASE B INHIBITOR; NORADRENALIN; PENTANE; PHENETHYLAMINE; PHENETHYLAMINE DERIVATIVE; SELEGILINE; SEROTONIN; TETRABENAZINE; TRYPTAMINE; TYRAMINE; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; BRAIN DEPTH STIMULATION; BRAIN NERVE CELL; CATECHOLAMINE RELEASE; CONTROLLED STUDY; DOPAMINE RELEASE; DRUG DESIGN; DRUG POTENCY; DRUG SELECTIVITY; DRUG SYNTHESIS; MALE; NEUROPROTECTION; NEUROTRANSMISSION; NONHUMAN; NORADRENALIN RELEASE; RAT; SEROTONIN RELEASE; STRUCTURE ACTIVITY RELATION;

AMPHETAMINES; AMYLOID; ANIMALS; AVOIDANCE LEARNING; BENZOFURANS; BRAIN; BRAIN STEM; CATECHOLAMINES; CELLS, CULTURED; ELECTRIC STIMULATION; HIPPOCAMPUS; MONOAMINE OXIDASE; NEURONS; PHENETHYLAMINES; RATS; SELEGILINE; SEROTONIN; STRUCTURE-ACTIVITY RELATIONSHIP; TRYPTAMINES; TYRAMINE;

EID: 0035007209     PISSN: 09680896     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0968-0896(01)00002-5     Document Type: Article

References (40)

1. Knoll J. Pharmacol. Toxicol. 75:1994;65.
2. Knoll J. Biomed. & Pharmacother. 49:1995;187.
3. Knoll J. Exp. Gerontol. 32:1997;539.
4. Knoll, J. Neurobiol. 2000, 8, 179.
5. Knoll J., Miklya I., Knoll B., Markó R., Rácz D. Life Sci. 58:1996;2101.
6. Knoll J., Miklya I., Knoll B., Markó R., Kelemen K. Life Sci. 58:1996;817.
7. Knoll J., Ecseri Z., Kelemen K., Nievel J., Knoll B. Arch. int. Pharmacodyn. Thér. 155:1965;. 154.
8. Knoll J. Mech. Ageing Dev. 46:1988;237.
9. Tatton W.G., Greenwood C.E. J. Neurosci. Res. 30:1991;666.
10. Tetrud J.W., Langston J.W. Science. 245:1989;519.
11. New Engl. J. Med. 321:1989;1364.
12. Sano M., Ernesto C., Thomas R.G., Klauber M.R., Schafer K., Grundman M., Woodbury P., Growdon J., Cotman C.W., Pfeiffer E., Schneider L.S., Thal L.J. New Engl. J. Med. 336:1997;1216.
13. Knoll J. Pharm. Toxicol. 82:1998;57.
14. Knoll J., Magyar K. Adv. Bioch. Psychopharmacol. 5:1972;393.
15. Knoll J., Knoll B., Török Z., Timár J., Yasar S. Arch. Int. Pharmacodyn. Thér. 316:1992;. 5.
16. Knoll J. Pharm. Toxicol. 70:1992;317.
17. Knoll J., Miklya I. Arch. int. Pharmacodyn. Thér. 328:1994;1.
18. Knoll J., Miklya I. Life Sci. 56:1995;611.
19. Knoll J. J. Neural Transm. 43:1978;177.
20. Hársing R.G., Magyar K., Takes K., Vizi E.S., Knoll J. Pol. J. Pharmacol. Pharm. 31:1979;297.
21. Salonen T., Haapalinna A., Heinonen E., Suhonen J., Hervonen A. Acta Neuropathol. 91:1996;466.
22. Cohen P., Pasik P., Cohen B., Leist A., Mitileneou C., Yahr M.D. Eur. J. Pharmacol. 106:1984;209.
23. Finnegan K.T., Skratt J.J., Irvin I., DeLanney L.E., Langston J.W. Eur. J. Pharmacol. 184:1990;119.
24. Knoll J., Tóth V., Kummert M., Sugár J. Mech. Ageing Dev. 63:1992;157.
25. Watt J.A., Pike C.J., Walencewicz-Wasserman A.J., Cotman C.W. Brain Res. 661:1994;147.
26. Knoll J. Acta Neurol. Scand. 95(Suppl.):1983;57.
27. Knoll, J., Dopamine, Ageing and Disease. Borsy, J., Kerescsen, L., György, L. Eds.; Pergamon, Akadémiai Kiadó: Budapest, 1986, pp 7-26.
28. Knoll J. J. Neural Transm. 25:1987;45.
29. Knoll J. Acta Neurol. Scand. 126:1989;83.
30. Hoffman, B. B.; Lefkowitz, R. J. In Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed.; Hardman, J. G., Limbird, L. E. Eds. McGraw-Hill: New York; 1996, pp 199-248.
31. Varga E., Tringer L. Acta Med. Acad. Sci. Hung. 23:1967;289.
32. Mann J.J., Gershon S. Life Sci. 26:1980;877.
33. Knoll J., Dallo J., Yen T.T. Life Sci. 45:1989;525.
34. Knoll J., Yen T.T., Miklya I. Life Sci. 54:1994;1047.
35. Milgram N.W., Racine R.K., Nellis P., Mendonca A., Ivy G.O. Life Sci. 47:1990;415.
36. Kitani K., Kanai S., Sato Y., Ohda M., Ivy G.O., Carrillo M.C. Life Sci. 52:1993;281.
37. Stoll S., Hafner U., Kranzlin B., Muller W.E. Neurobiol. Aging. 18:1997;205.
38. Ruehl W.W., Entriken T.L., Muggenburg B.A., Bruzette D.S., Griffith W.G., Hahn F.F. Life Sci. 61:1997;1037.
39. Knoll, J.; Simay, A.; Szinnyei, E.; Somfai, E.; Török, Z.; Mozsalitz, K.; Bergmann, J. WO88/02254.
40. Huet, J., Bull. Soc. Chem. Fr., 1964, 952.